Solacium

Solacium is a Brazilian specialty pharmaceutical company that focuses on the commercialization and distribution of high-complexity medications. The company operates primarily in the institutional market, providing therapies for oncology, hematology, nephrology, and rare diseases. Solacium aims to bridge the gap between innovative global therapies and the Brazilian healthcare system through strategic licensing and distribution agreements. In 2018, the company was acquired by Hypera Pharma, the largest pharmaceutical company in Brazil, to enhance its presence in the high-growth specialty and hospital segments. Today, it functions as a specialized unit within Hypera's portfolio, leveraging extensive local expertise to manage the regulatory and commercial lifecycle of advanced therapeutics.